BNET Industries
Last Fiscal Year Sales:$37.5M
- Private
- US
Dow Jones Description
Founded in 1897, Lonza is one of the world's leading suppliers to the pharmaceutical, healthcare and life science industries. Its products and services span its customers' needs from research to final product manufacture. Lonza is the global leader in the production and support of pharmaceutical active ingredients both chemically as well as biotechnologically. Biopharmaceuticals are one of the key growth drivers of the pharmaceutical and biotechnology industries. Lonza has strong capabilities in large and small molecules, peptides, amino acids and niche bioproducts which play an important role in the development of novel medicines and healthcare products. Lonza is also a leading provider of value added chemical and biotech ingredients to the nutrition, hygiene, preservation, agro and personal care markets.
Chief Executive Officer
Stefan BorgasNumber of Employees 2
Peer Companies
NAICS Code All Other Basic Organic Chemical Manufacturing: 325199
News & Analysis
Filter by
larex inc. - All News and Analysis
Lonza acquires assets from Larex, Inc
- 2006-08-01
* Lonza Group acquired Arabinogalactan business assets from Larex, Inc., which includes intellectual property, proprietary processing technology, manufacturing operations in Cohasset, MN, certain inventory and customer lists. This acquisition further expands Lonza's portfolio of nutrition businesses within organic fine and performance chemicals.
Ban on Animal Feed Antibiotics Opens Door to New Alternatives.
- 2000-03-13
WITH EUROPE moving toward a total ban on the use of antibiotics in animal feed and similar battles being waged on the US home front, the animal feed industry is racing to develop alternative supplements that promote growth. Industry sources predict that by the end of 2001,...
LAREX Inc.
- 1999-04-26
LAREX Inc., St. Paul, Minn., now offers Larex AC-9B, a natural non-antibiotic product for animal feed. Larex's collaboration partner, Finland-based Suomen Rehu, will have the first option to use the new product in the Scandinavian countries and Baltic states during 1999.
Duluth News-Tribune, Minn., BizBuzz Column.
- 1998-09-30
Knight Ridder/Tribune Business News Sep. 29--NORTHWEST ONLINE: Northwest Airlines has upgraded its Web site with new features and capabilities designed to expand customers' ability to complete their travel plans. With the latest version installed this past weekend, Northwest and KLM customers...
Larex Inc - expansion of global distributor network - Brief Article
- 1998-09-01
Larex Inc., St. Paul, Minn., has expanded its worldwide distributor network with the signing of eight new distributors in 1997.
Larex, Lawter Offer Ink Additives.(Larex Inc., Lawter International)(deal to market LaraPrint product line)
- 1998-05-25
Larex Inc., St. Paul, Minn., has signed a multi-year agreement with Lawter International to develop and market its LaraPrint ink additive product line to the global graphics market. Larex expects the agreement to result in the sale of several million pounds of...
Larex Inc - agreement with General Nutrition Corp - Brief Article
- 1998-05-01
Larex Inc. announced that in 1997 it entered into an agreement for General Nutrition Corp. GNC to have the exclusive right to include FiberAid[Tm] in GNC nutritional beverages in the retail health food market.
Food phosphates are benefitting from processed foods advances.
- 1998-03-09
The Advancing Complexity of food formulations together with the continuing growth of processed foods is raising the demand for food phosphates. Manufacturers are moving to meet the growing needs of the food industry by increasing both their production and formulation...
Growing demand spurs new capacity for spirulina. (Pharma & Fine Chemicals)
- 1996-12-16
RESPONDING TO growing demand, US producers are increasing capacity for spirulina, a species of blue-green microalgae cultured commercially in vast aquacenters. Meanwhile, several new, smaller producers have been coming on line throughout India and Asia. Although the biologically produced "phytonutrient" has...
Growing Demand Spurs New Capacity for Spirulina
- 1996-12-16
RESPONDING TO growing demand, US producers are increasing capacity for spirulina, a species of blue-green microalgae cultured commercially in vast aquacenters. Meanwhile, several new, smaller producers have been coming on line throughout India and Asia. Although the biologically produced "phytonutrient" has been ...
- 1
- 2
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Stefan Borgas | Chief Executive Officer |
| Shawn Cavanagh | President, Lonza Bioscience |
| Toralf Haag | Chief Financial Officer |
| Claudio Abacherli | Quality Systems Manager |
| Deborah Thompson | Senior Product Manager |
| Robert Cox | Gmp Compliance Manager |
| Stephanie Nickles | Tactical Segment Manager, Cell Biology, Lonza Walkersville, Inc. |
| Dominik Werner | |
| Gines Garcia | |
| Guido Lularevic | |
| Karin Senggen | Apprentice |
| Lukas Utiger | Head of Organic Fine&Performance Chemicals |
| Marcela Cechova | Head of Global Human Resources |
| Nicola Rakovic | Apprentice |
| Stephan Kutzer | Head of Biopharmaceuticals |
| Stephan Rosenberger | Head of Cq |
| Uwe H. Bohlke | Head of Exclusive Synthesis |
| Dennis Deconcini | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Daphne Jackson | Board of Directors |
| Gerhard N. Mayr | Board of Directors |
| Rolf Soiron | Board of Directors |
Stefan Borgas (1964) Holds a degree in business administration from the University of Saarbruecken and a lic. oec. HSG degree (MBA) from the University of St. Gallen
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Chief Executive Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | President, Lonza Bioscience | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Chief Financial Officer | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Quality Systems Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Senior Product Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Gmp Compliance Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Tactical Segment Manager, Cell Biology, Lonza Walkersville, Inc. | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Apprentice | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Head of Organic Fine&Performance Chemicals | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Head of Global Human Resources | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Apprentice | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Head of Biopharmaceuticals | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Head of Cq | Current |
Uwe H. Bohlke (1964) Holds a degree and a PhD in mechanical engineering as well as a degree in economics from the RWTH Aachen University.
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Head of Exclusive Synthesis | Current |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Deconcini McDonald Yetwin & Lacy | Partner | Current |
| Natrol, Inc. | Director of the Company | Current |
| Natrol, Inc. | Chairman of the Governance and Nominating Committee | Current |
| The Regents | Board of Directors | Current |
| Corrections Corporation of America | Board of Directors | Current |
| National Center for Missing and Exploited Children | Board of Directors | Current |
| Ceramic Protection Corporation | Board of Directors | Current |
| Larex Inc | Director | Current |
| Natrol, Inc. | Board of Directors | Former |
| The University of Arizona | L.L.B. | Former |
Gerhard N. Mayr, Independent Director, Member of the Remuneration and Appointments Committee. A native of Austria, Gerhard Mayr received a master's degree in chemical engineering from the Swiss Federal Institute of Technology (Zurich, Switzerland) in 1969, and a master of business administration degree from Stanford University in 1972. In March, 2004, Gerhard Mayr retired as executive vice president of pharmaceutical operations at Eli Lilly & Company after 32 years of service. He had been responsible for global pharmaceutical operations and sales and marketing worldwide at Lilly - a leading innovation-driven corporation. Gerhard Mayr is past chairman of both the International Executive Committee and the Europe Committee of the Pharmaceutical Research Manufacturers of America. He was a board member of the European Federation of the Pharmaceutical Industry from 1995-97 and 2000-2002. Member of the Board of Bank Austria-Creditanstalt AG, and a member of the board of OMV AG. He is a member of the Apax Healthcare Advisory Board, a member of the board of Project Hope, and a board member of the Vienna Science-Research and Technology Foundation.
| Organization | Position | Status |
|---|---|---|
| UCB Pharma Inc. | Independent Director | Current |
| OMV AG | Member of the Board | Current |
| UCB Pharma Inc. | Board of Directors | Current |
| UCB, S.A. | Board of Directors | Current |
| Carniking.Com | Board of Directors | Current |
| Larex Inc | Board of Directors | Current |
| Lonza Biologics and Celltech Therapeutics Ltd | Board of Directors | Current |
| Carnipure | Board of Directors | Current |
| Niacinamide | Board of Directors | Current |
| Lonza Inc. | Board of Directors | Current |
| High Performance Materials | Board of Directors | Current |
| Metaldehyde | Board of Directors | Current |
| Lonzapcproducts | Board of Directors | Current |
| Biocatalytics, Inc. | Special Advisor To the Codexis Board | Current |
| Highland Ophthalmology Associates, LLC | Board of Directors | Current |
| Alcon, Inc. | Board of Directors | Current |
| Natrulon | Board of Directors | Current |
| Lonza Group Ltd. | Board of Directors | Current |
| Codexis, Inc. | Board of Directors | Current |
| Carnitine | Board of Directors | Current |
| Hcnderivatives | Board of Directors | Current |
| Highland Ophthalmology Associates, LLC | Committee Member | Current |
| Eli Lilly and Company | Executive Vice President | Former |
| Eli Lilly and Company | Sales Representative | Former |
| Pharmaceutical Research and Manufacturers of America | chairman | Former |
| Swiss Federal Institute of Technology | Masters Degree In Chemical Engineering | Former |
| Stanford University | Master of Business Administration | Former |
| Guidant Corporation | member | Former |
| OMV AG | member | Former |
| Project Hope | member | Former |
| UCB Pharma Inc. | Member | Former |
| Organization | Position | Status |
|---|---|---|
| Larex Inc | Board of Directors | Current |
Industry Transcripts by Seeking Alpha
-
Brown Shoe Co. Inc. Q3 2009 Earnings Call Transcript
on Nov 24, 2009about BWS
-
Daktronics Inc. F2Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 24, 2009about DAKT
-
Haynes International Inc. F4Q09 (Qtr End 09/30/09) Earnings Call Transcript
on Nov 24, 2009about HAYN
-
Valspar Corp. F4Q09 (Qtr End 30/10/09) Earnings Call Transcript
on Nov 23, 2009about VAL
-
Donaldson Company Inc. F1Q10 (Qtr End 31/10/09) Earnings Call Transcript
on Nov 19, 2009about DCI
Glass Door
Manufacturing Industry Companies
| Company | Employer Rating |
| Alcoa |  |
| United Technologies | |
| BAE SYSTEMS (United Kingdom) | |
| Textron |  |
| Boeing | |
IndustryTop Rated
